Global Extracorporeal Membrane Oxygenation Machines Market 2021-2025

世界の体外式膜型人工肺(ECMO)市場2021-2025:静脈-静脈、静脈-動脈

◆タイトル:Global Extracorporeal Membrane Oxygenation Machines Market 2021-2025
◆商品コード:IRTNTR40185
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2021年10月20日
◆ページ数:約120
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥0見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥0見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥0見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

テクナビオ社は、体外式膜型人工肺(ECMO)の世界市場規模が2021年~2025年まで年平均10.27%成長し、239.83百万ドルに達すると予測しています。本市場調査レポートでは、世界の体外式膜型人工肺(ECMO)市場について調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、モダリティ別(静脈-静脈、静脈-動脈)分析、顧客状況、地域別状況、企業状況、企業分析など、以下の構成でまとめております。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・体外式膜型人工肺(ECMO)の世界市場規模:モダリティ別(静脈-静脈、静脈-動脈)
・顧客状況
・地域別状況
・企業状況
・企業分析

Global Extracorporeal Membrane Oxygenation Machines Market 2021-2025
Technavio has been monitoring the extracorporeal membrane oxygenation machines market and it is poised to grow by $ 239.83 mn during 2021-2025, progressing at a CAGR of 10.27% during the forecast period. Our report on the extracorporeal membrane oxygenation machines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing incidence of respiratory and heart failure and rising number of new product launches. In addition, the increasing incidence of respiratory and heart failure is anticipated to boost the growth of the market as well.
The extracorporeal membrane oxygenation machines market analysis includes the modality segment and geographic landscape.

Technavio’s extracorporeal membrane oxygenation machines market is segmented as below:

By Modality
• Veno-venous
• Veno-arterial

By Geographical Landscape
• North America
• Europe
• Asia
• ROW

This study identifies the growing number of transplant proceduresas one of the prime reasons driving the extracorporeal membrane oxygenation machines market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on extracorporeal membrane oxygenation machines market covers the following areas:
• Extracorporeal membrane oxygenation machines market sizing
• Extracorporeal membrane oxygenation machines market forecast
• Extracorporeal membrane oxygenation machines market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading extracorporeal membrane oxygenation machines market vendors that include ALung Technologies Inc., Eurosets Srl, Fresenius Medical Care AG and Co. KGaA, Getinge AB, LivaNova Plc, Medtronic Plc, MicroPort Scientific Corp., Nipro Corp., OriGen Biomedical Inc., and Terumo Corp. Also, the extracorporeal membrane oxygenation machines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/extracorporeal-membrane-oxygenation-machine-market-industry-analysis

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

【資料の目次】

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2020
o Market outlook: Forecast for 2020 – 2025
• Five Forces Analysis
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Modality
o Market segments
o Comparison by Modality
o Veno-venous – Market size and forecast 2020-2025
o Veno-arterial – Market size and forecast 2020-2025
o Market opportunity by Modality
• Customer landscape
o Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2020-2025
o Europe – Market size and forecast 2020-2025
o Asia – Market size and forecast 2020-2025
o ROW – Market size and forecast 2020-2025
o Key leading countries
o Market opportunity By Geographical Landscape
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o ALung Technologies Inc.
o Eurosets Srl
o Fresenius Medical Care AG and Co. KGaA
o Getinge AB
o LivaNova Plc
o Medtronic Plc
o MicroPort Scientific Corp.
o Nipro Corp.
o OriGen Biomedical Inc.
o Terumo Corp.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibits
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global – Market size and forecast 2020 – 2025 ($ million)
• 13: Global market: Year-over-year growth 2020 – 2025 (%)
• 14: Five forces analysis 2020 & 2025
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition – Five forces 2020
• 21: Modality – Market share 2020-2025 (%)
• 22: Comparison by Modality
• 23: Veno-venous – Market size and forecast 2020-2025 ($ million)
• 24: Veno-venous – Year-over-year growth 2020-2025 (%)
• 25: Veno-arterial – Market size and forecast 2020-2025 ($ million)
• 26: Veno-arterial – Year-over-year growth 2020-2025 (%)
• 27: Market opportunity by Modality
• 28: Customer landscape
• 29: Market share By Geographical Landscape 2020-2025 (%)
• 30: Geographic comparison
• 31: North America – Market size and forecast 2020-2025 ($ million)
• 32: North America – Year-over-year growth 2020-2025 (%)
• 33: Europe – Market size and forecast 2020-2025 ($ million)
• 34: Europe – Year-over-year growth 2020-2025 (%)
• 35: Asia – Market size and forecast 2020-2025 ($ million)
• 36: Asia – Year-over-year growth 2020-2025 (%)
• 37: ROW – Market size and forecast 2020-2025 ($ million)
• 38: ROW – Year-over-year growth 2020-2025 (%)
• 39: Key leading countries
• 40: Market opportunity By Geographical Landscape ($ million)
• 41: Impact of drivers and challenges
• 42: Vendor landscape
• 43: Landscape disruption
• 44: Industry risks
• 45: Vendors covered
• 46: Market positioning of vendors
• 47: ALung Technologies Inc. – Overview
• 48: ALung Technologies Inc. – Product and service
• 49: ALung Technologies Inc. – Key offerings
• 50: ALung Technologies Inc. – Key customers
• 51: ALung Technologies Inc. – Segment focus
• 52: Eurosets Srl – Overview
• 53: Eurosets Srl – Product and service
• 54: Eurosets Srl – Key offerings
• 55: Eurosets Srl – Key customers
• 56: Eurosets Srl – Segment focus
• 57: Fresenius Medical Care AG and Co. KGaA – Overview
• 58: Fresenius Medical Care AG and Co. KGaA – Business segments
• 59: Fresenius Medical Care AG and Co. KGaA – Key offerings
• 60: Fresenius Medical Care AG and Co. KGaA – Key customers
• 61: Fresenius Medical Care AG and Co. KGaA – Segment focus
• 62: Getinge AB – Overview
• 63: Getinge AB – Business segments
• 64: Getinge AB – Key offerings
• 65: Getinge AB – Key customers
• 66: Getinge AB – Segment focus
• 67: LivaNova Plc – Overview
• 68: LivaNova Plc – Business segments
• 69: LivaNova Plc – Key offerings
• 70: LivaNova Plc – Key customers
• 71: LivaNova Plc – Segment focus
• 72: Medtronic Plc – Overview
• 73: Medtronic Plc – Business segments
• 74: Medtronic Plc – Key offerings
• 75: Medtronic Plc – Key customers
• 76: Medtronic Plc – Segment focus
• 77: MicroPort Scientific Corp. – Overview
• 78: MicroPort Scientific Corp. – Business segments
• 79: MicroPort Scientific Corp. – Key offerings
• 80: MicroPort Scientific Corp. – Key customers
• 81: MicroPort Scientific Corp. – Segment focus
• 82: Nipro Corp. – Overview
• 83: Nipro Corp. – Business segments
• 84: Nipro Corp. – Key offerings
• 85: Nipro Corp. – Key customers
• 86: Nipro Corp. – Segment focus
• 87: OriGen Biomedical Inc. – Overview
• 88: OriGen Biomedical Inc. – Product and service
• 89: OriGen Biomedical Inc. – Key offerings
• 90: OriGen Biomedical Inc. – Key customers
• 91: OriGen Biomedical Inc. – Segment focus
• 92: Terumo Corp. – Overview
• 93: Terumo Corp. – Business segments
• 94: Terumo Corp. – Key offerings
• 95: Terumo Corp. – Key customers
• 96: Terumo Corp. – Segment focus
• 97: Currency conversion rates for US$
• 98: Research Methodology
• 99: Validation techniques employed for market sizing
• 100: Information sources
• 101: List of abbreviations



【掲載企業】

ALung Technologies Inc., Eurosets Srl, Fresenius Medical Care AG and Co. KGaA, Getinge AB, LivaNova Plc, Medtronic Plc, MicroPort Scientific Corp., Nipro Corp., OriGen Biomedical Inc., Terumo Corp.

★調査レポート[世界の体外式膜型人工肺(ECMO)市場2021-2025:静脈-静脈、静脈-動脈] (Global Extracorporeal Membrane Oxygenation Machines Market 2021-2025 / IRTNTR40185)販売に関する免責事項
[世界の体外式膜型人工肺(ECMO)市場2021-2025:静脈-静脈、静脈-動脈] (Global Extracorporeal Membrane Oxygenation Machines Market 2021-2025 / IRTNTR40185)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆